Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Royalty Pharma plc (RPRX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/03/2023 |
4
| Fernandez Henry A (Director) has filed a Form 4 on Royalty Pharma plc|
Txns:
| Granted 1,384 shares
@ $27.0775, valued at
$37.5k
|
|
| 10/03/2023 |
4
| Bassler Bonnie L (Director) has filed a Form 4 on Royalty Pharma plc|
Txns:
| Granted 1,384 shares
@ $27.0775, valued at
$37.5k
|
|
| 10/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 10/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/11/2023 |
4
| Coyne Terrance P. (EVP & CFO) has filed a Form 4 on Royalty Pharma plc|
Txns:
| Sold 37,500 shares
@ $30.7183, valued at
$1.2M
Sold 37,500 shares
@ $30.7491, valued at
$1.2M
|
|
| 08/09/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/08/2023 |
4
| RIGGS RORY B (Director) has filed a Form 4 on Royalty Pharma plc|
Txns:
| Gifted 6,500 options to buy
@ $0 |
|
| 08/08/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/08/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/08/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/08/2023 |
8-K
| Quarterly results |
| 07/14/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/12/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/30/2023 |
4
| Fernandez Henry A (Director) has filed a Form 4 on Royalty Pharma plc|
Txns:
| Granted 1,208 shares
@ $31.0273, valued at
$37.5k
|
|
| 06/30/2023 |
4
| Bassler Bonnie L (Director) has filed a Form 4 on Royalty Pharma plc|
Txns:
| Granted 1,208 shares
@ $31.0273, valued at
$37.5k
|
|
| 06/28/2023 |
4
| Legorreta Pablo G. (CEO, Chairman of the Board) has filed a Form 4 on Royalty Pharma plc|
Txns:
| Bought 130,000 shares
@ $29.5136, valued at
$3.8M
|
|
| 06/06/2023 |
4
| Lloyd George W. (EVP, Investments & CLO) has filed a Form 4 on Royalty Pharma plc|
Txns:
| Sold 92,221 shares
@ $33.6453, valued at
$3.1M
Sold 1,686 shares
@ $33.5362, valued at
$56.5k
Sold 19,215 shares
@ $33.5387, valued at
$644.4k
Sold 79,099 shares
@ $33.8158, valued at
$2.7M
|
|
| 06/02/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/02/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/24/2023 |
4
| Legorreta Pablo G. (CEO, Chairman of the Board) has filed a Form 4 on Royalty Pharma plc|
Txns:
| Bought 150,000 shares
@ $32.2496, valued at
$4.8M
|
|
| 05/22/2023 |
4
| RIGGS RORY B (Director) has filed a Form 4 on Royalty Pharma plc|
Txns:
| Sold 1,750,000 shares
@ $32.82, valued at
$57.4M
|
|
| 05/22/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/17/2023 |
4
| Legorreta Pablo G. (CEO, Chairman of the Board) has filed a Form 4 on Royalty Pharma plc|
Txns:
| Bought 160,388 shares
@ $33.5669, valued at
$5.4M
Bought 69,612 shares
@ $32.9411, valued at
$2.3M
|
|
| 05/15/2023 |
4
| Legorreta Pablo G. (CEO, Chairman of the Board) has filed a Form 4 on Royalty Pharma plc|
Txns:
| Gifted 10,269 options to buy
@ $0
Gifted 10,269 options to buy
@ $0 |
|
| 05/12/2023 |
4
| RIGGS RORY B (Director) has filed a Form 4 on Royalty Pharma plc|
Txns:
| Converted 300,000 shares
@ $0
Converted 30,000 options to buy
@ $0 |
|
| 05/09/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/09/2023 |
8-K
| Quarterly results |
| 04/27/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 03/31/2023 |
4
| Fernandez Henry A (Director) has filed a Form 4 on Royalty Pharma plc|
Txns:
| Granted 1,049 shares
@ $35.7276, valued at
$37.5k
|
|
| 03/31/2023 |
4
| Bassler Bonnie L (Director) has filed a Form 4 on Royalty Pharma plc|
Txns:
| Granted 1,049 shares
@ $35.7276, valued at
$37.5k
|
|
| 03/28/2023 |
8-K
| Quarterly results |
| 03/15/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
|
|
|